Roche ranked as one of the top three most sustainable healthcare companies in the Dow Jones Sustainability Indices for the thirteenth year running

The ranking acknowledges Roche’s commitment to sustainability as an integral part of its business strategy Roche performed particularly well in Operational Eco-Efficiency, Environmental and Social Reporting Basel, 15 November 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) has again been recognised as one of the most sustainable companies in the Pharmaceuticals index of the Dow... Read more

Whole Slide Imaging of the Pancreas to Study Type 1 Diabetes

Type 1 diabetes is a chronic autoimmune disease in which the pancreas produces little or no insulin. Insulin is a hormone needed to allow sugar (glucose) to enter cells to produce energy. The exact cause of type 1 diabetes is unknown. Usually, the body’s own immune system mistakenly destroys the insulin-producing cells (called beta cells)... Read more

Thermo Fisher Scientific Selects Mebane, N.C. as Site for New Manufacturing Facility

Thermo Fisher Scientific Selects Mebane, N.C. as Site for New Manufacturing Facility $192.5 million U.S. government contract will help fund center of excellence to boost domestic supply of critically needed laboratory plastics WALTHAM, Mass., Nov. 12, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, today announced it will build a state-of-the-art manufacturing... Read more

Ronapreve approved by European Commission to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease

EU marketing authorisation follows approvals in Japan, the United Kingdom and Australia Approval based on data demonstrating Ronapreve reduced risk of hospitalisation in certain patients with mild to moderate disease and reduced risk of symptomatic COVID-19 infections in people exposed to the virus Basel, 12 November 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today... Read more

Xylem Inc. Declares Fourth Quarter Dividend of 28 Cents per Share

RYE BROOK, N.Y.–(BUSINESS WIRE)–Nov. 11, 2021– The Board of Directors of Xylem Inc. (NYSE: XYL) has declared a third quarter dividend of $0.28 per share payable on December 21, 2021 to shareholders of record as of November 23, 2021. About Xylem Xylem (XYL) is a leading global water technology company committed to solving critical water... Read more

PacBio to Present at Upcoming Investor Conferences

MENLO PARK, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) — PacBio announced today that its executives will be speaking at the following investor conferences: Stifel 2021 Virtual Healthcare Conference on November 16, 2021, at 11:20 am Eastern Time (8:20 am Pacific Time) Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum on November 18,... Read more

CHMP recommends EU approval of Ronapreve to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease

Recommendation based on data demonstrating Ronapreve reduced risk of hospitalisation in certain patients with mild to moderate disease and reduced risk of symptomatic COVID-19 infections in people exposed to the virus Ronapreve’s combination approach continues to retain neutralisation activity against variants of concern Basel, 11 November 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today... Read more

Brooks Automation Reports Results of Fourth Quarter of Fiscal 2021, Ended September 30, 2021, and Announces Quarterly Cash Dividend

Brooks Automation Reports Results of Fourth Quarter of Fiscal 2021, Ended September 30, 2021, and Announces Quarterly Cash Dividend Strong Double-Digit Growth Quarter Underscores Robust Demand Environment in Life Sciences CHELMSFORD, Mass., Nov. 10, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today reported financial results for the fiscal quarter ended September 30, 2021. Summary of... Read more

New IVD System Enables Assay Developers and Clinical Laboratories to Accelerate Molecular Diagnostics Growth

New IVD System Enables Assay Developers and Clinical Laboratories to Accelerate Molecular Diagnostics Growth Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow CARLSBAD, Calif., Nov. 9, 2021 /PRNewswire/ — As assay developers and clinical testing laboratories consider next steps for molecular diagnostics post-pandemic, a new in vitro diagnostic (IVD)... Read more

Bruker Corporation to Participate in the 2021 Jefferies London Healthcare Conference

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2021 Jefferies London Healthcare Conference. Gerald Herman, Executive Vice President & Chief Financial Officer will participate in an analyst-moderated question and answer session on behalf of the Company on Tuesday, November 16, 2021 at 12:20 PM GMT. A live audio webcast... Read more